v3.26.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Jun. 30, 2025
Current Assets    
Cash $ 968 $ 2,518
Total Current Assets 968 2,518
Total Assets 968 2,518
Current Liabilities    
Accounts payable and accrued expenses 9,250 28,804
Advances from related parties 514,912 417,771
Common stock payable 9,559 9,559
Deferred revenue 34,109 37,506
Total Current Liabilities 567,830 493,640
Commitments and Contingencies (Note 7)
Stockholders’ Deficit    
Common stock, $0.001 par value, 300,000,000 shares authorized; 130,201,179 shares issued at March 31,2026 and June 30, 2025 130,201 130,201
Additional paid-in-capital 13,443,466 13,443,466
Accumulated deficit (14,140,537) (14,064,797)
Total Stockholders’ Deficit (566,862) (491,122)
Total Liabilities and Stockholders' Deficit 968 2,518
Series A Preferred Stock [Member]    
Stockholders’ Deficit    
Preferred stock value 6 6
Series B Preferred Stock [Member]    
Stockholders’ Deficit    
Preferred stock value $ 2 $ 2